Hereditary Genetic Testing Global Market Report 2025

Hereditary Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for hereditary genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hereditary genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:
• The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Predictive And Presymptomatic Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing; Other Types

2) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing 

3) By Clinical Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Rare Diseases Genetic Testing

4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Direct To Consumer (DTC) Genetic Testing Companies

Subsegments:

1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction; Testing For Inherited Cancer Risks; Cardiovascular Disease Risk Testing; Neurodegenerative Disease Risk Testing

2) By Carrier Testing: Testing For Inherited Genetic Disorders; Genetic Screening For Autosomal Recessive Diseases; Testing For Carrier Status Of Inherited Conditions

3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis and Chorionic Villus Sampling (CVS); Newborn Screening For Genetic Disorders; Preconception Genetic Screening

4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders; Testing For Inherited Syndromes and Congenital Diseases; Diagnostic Testing For Cancer and Tumor Profiling

5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy; Testing For Drug Sensitivities and Side Effects; Personalized Medicine and Treatment Optimization

6) By Other Types: Genetic Testing For Wellness And Lifestyle; Genetic Testing For Ancestry And Genealogy; Research-Oriented Genetic Testing

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Amgen Inc.; Laboratory Corporation of America Holdings

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Show more